Central America Cancer Treatment

• South and Central America Monoclonal Antibodies Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Source (Human, Humanized, Chimeric, and Murine), Production Method (In-Vitro, and In-Vivo), Indication (Cancer, Autoimmune Diseases, Infectious Diseases, Inflammatory Diseases, Microbial Diseases, and Others), Application (Therapeutic Applications, Diagnostic Applications, and Research Applications), End-User (Hospitals, Research Institutes, and Others)

  Apr 07, 2022  |  Published by: The Insight Partners  |  USD 3,000

  ... Diseases, Microbial Diseases, and Others), Application (Therapeutic Applications, Diagnostic Applications, and Research Applications), End-User (Hospitals, Research Institutes, and Others) The South & Central America monoclonal antibodies market is expected to reach US$ 10,847.3 million by ... Read More

• Central America (Costa Rica, Panama, Guatemala, Dominican Republic) Acute Myeloid Leukemia Drugs Market

  Apr 01, 2022  |  Published by: Data Bridge Market Research  |  USD 3,500

  ... 5.5% in the forecast period of 2022 to 2029. The new market report contains data for the historic year 2020, the base year of calculation is 2021 and the forecast period is 2022 to 2029. ... Read More

< prev 1 2 3 next >